Differences in the processing of chylomicron remnants and beta-VLDL by macrophages
- PMID: 2280181
Differences in the processing of chylomicron remnants and beta-VLDL by macrophages
Abstract
To gain a detailed understanding of those factors that govern the processing of dietary-derived lipoprotein remnants by macrophages we examined the uptake and degradation of rat triacylglycerol-rich chylomicron remnants and rat cholesterol-rich beta-very low density lipoprotein (beta-VLDL) by J774 cells and primary cultures of mouse peritoneal macrophages. The level of cell associated 125I-labeled beta-VLDL and 125I-labeled chylomicron remnants reached a similar equilibrium level within 2 h of incubation at 37 degrees C. However, the degradation of 125I-labeled beta-VLDL was two to three times greater than the degradation of 125I-labeled chylomicron remnants at each time point examined, with rates of degradation of 161.0 +/- 36.0 and 60.1 +/- 6.6 ng degraded/h per mg cell protein, respectively. At similar extracellular concentrations of protein or cholesterol, the relative rate of cholesteryl ester hydrolysis from [3H]cholesteryl oleate/cholesteryl [14C]oleate-labeled chylomicron remnants was one-third to one-half that of similarly labeled beta-VLDL. The reduction in the relative rate of chylomicron remnant degradation by macrophages occurred in the absence of chylomicron remnant-induced alterations in low density lipoprotein (LDL) receptor recycling or in retroendocytosis of either 125I-labeled lipoprotein. The rate of internalization of 125I-labeled beta-VLDL by J774 cells was greater than that of 125I-labeled chylomicron remnants, with initial rates of internalization of 0.21 ng/min per mg cell protein for 125I-labeled chylomicron remnants and 0.39 ng/min per mg cell protein for 125I-labeled beta-VLDL. The degradation of 125I-labeled chylomicron remnants and 125I-labeled beta-VLDL was dependent on lysosomal enzyme activity: preincubation of macrophages with the lysosomotropic agent monensin reduced the degradation of both lipoproteins by greater than 90%. However, the pH-dependent rate of degradation of 125I-labeled chylomicron remnants by lysosomal enzymes isolated from J774 cells was 50% that of 125I-labeled beta-VLDL. The difference in degradation rates was dependent on the ratio of lipoprotein to lysosomal protein used and was greatest at ratios greater than 50. The degradation of 125I-labeled beta-VLDL by isolated lysosomes was reduced 30-40% by preincubation of beta-VLDL with 25-50 micrograms oleic acid/ml, suggesting that released free fatty acids could cause the slower degradation of chylomicron remnants. Thus, differences in the rate of uptake and degradation of remnant lipoproteins of different compositions by macrophages are determined by at least two factors: 1) differences in the rates of lipoprotein internalization and 2) differences in the rate of lysosomal degradation.
Similar articles
-
Evidence that chylomicron remnants and beta-VLDL are transported by the same receptor pathway in J774 murine macrophage-derived cells.J Lipid Res. 1986 Oct;27(10):1062-72. J Lipid Res. 1986. PMID: 3025323
-
Transport of beta-very low density lipoproteins and chylomicron remnants by macrophages is mediated by the low density lipoprotein receptor pathway.J Biol Chem. 1987 Feb 15;262(5):2316-25. J Biol Chem. 1987. PMID: 3546288
-
Receptor-mediated uptake of remnant lipoproteins by cholesterol-loaded human monocyte-macrophages.J Biol Chem. 1985 Jul 25;260(15):8783-8. J Biol Chem. 1985. PMID: 2991220
-
Introduction to Lipids and Lipoproteins.2024 Jan 14. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–. 2024 Jan 14. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–. PMID: 26247089 Free Books & Documents. Review.
-
Postprandial lipoprotein metabolism: VLDL vs chylomicrons.Clin Chim Acta. 2011 Jul 15;412(15-16):1306-18. doi: 10.1016/j.cca.2011.04.018. Epub 2011 Apr 19. Clin Chim Acta. 2011. PMID: 21531214 Free PMC article. Review.
Cited by
-
Dyslipidemia in obesity: mechanisms and potential targets.Nutrients. 2013 Apr 12;5(4):1218-40. doi: 10.3390/nu5041218. Nutrients. 2013. PMID: 23584084 Free PMC article. Review.
-
FABP4 Expression in Subcutaneous Adipose Tissue Is Independently Associated with Circulating Triglycerides in Obesity.J Clin Med. 2023 Jan 28;12(3):1013. doi: 10.3390/jcm12031013. J Clin Med. 2023. PMID: 36769659 Free PMC article.
-
Undertreatment or Overtreatment With Statins: Where Are We?Front Cardiovasc Med. 2022 Apr 29;9:808712. doi: 10.3389/fcvm.2022.808712. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35571155 Free PMC article. Review.
-
Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo.J Clin Invest. 1991 Oct;88(4):1173-81. doi: 10.1172/JCI115419. J Clin Invest. 1991. PMID: 1918372 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources